This announcement is a separate document:
晨光生物：2024年半年度报告摘要
Chenguang Biotech Group: Summary of Half-Year Report in 2024.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
13:14
Institutions:
Shareholder: gtja
Rating: Neutral
Target price: HKD 5.60
In the first half of 2018, the company's performance is lower than the market consensus and our estimation, mainly due to the rise in production costs and asset impairment. The company
CITIC-1.75%
13:10
Malaysia becomes a BRICS partner country. Experts say this will help enhance the country's influence in Global cooperation.
13:00
Lian Ping: Rural Consumer in our country has enormous potential, suggesting the issuance of super long-term special treasury bonds worth 500 billion yuan for five consecutive years, specifically to support urbanization construction.
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.